Overcome the Challenges of PK Assay Development Using TrailBlazer Antibodies @BioRadLaboratoriesCorp
Overcome the Challenges of PK Assay Development Using TrailBlazer Antibodies  @BioRadLaboratoriesCorp
Uploaded February 2022 | Updated September 2026, 2 weeks ago
Imagine how good it would feel to start the development of your next pharmacokinetic (PK) assay with the confidence it’s going to work. Part of the challenge is sourcing highly specific, well-characterized antibodies in the ideal format and with the detection label needed for your chosen platform. In this webinar, we describe how TrailBlazer Antibodies are made using antibody phage display and a new modular antibody assembly platform based on SpyTag technology. The in vitro method facilitates generation of anti-idiotypic antibodies to address PK assay design for different drug modalities. SpyTag technology enables site-directed conjugation and rapid assembly of multiple bivalent and Ig-like formats.

Learn more at bio-rad-antibodies.com/trailblazer

Subscribe to the Bio-Rad channel: youtube.com/user/BioRadLifeScience?sub_confirmation=1

We Are Bio-Rad.

Our mission: To provide useful, high-quality products and services that advance scientific discovery and improve healthcare. At Bio-Rad, we are united behind this effort. These two objectives are the driving force behind every decision we make, from developing innovative ideas to building global solutions that help solve our customers' greatest challenges.

#CustomAntibodyGeneration #LigandBindingAssay #Bioanalysis

Connect with Bio-Rad Online:
Website: bio-rad.com
LinkedIn: linkedin.com/company/1613226
Facebook: facebook.com/biorad
Twitter: twitter.com/BioRadLifeSci
Instagram: @BioRadLabs
Snapchat: @BioRadLabs

©2022 Bio-Rad is a trademark of Bio-Rad Laboratories, Inc. in certain jurisdictions. All trademarks used herein are the property of their respective owner.

Music used by permission granted by royalty-free license from Pond5.com
Overcome the Challenges of PK Assay Development Using TrailBlazer AntibodiesBio Rad.io Podcast — The Rise of Digital TherapeuticsBio-Rads Backyard BBQSingle-Cell ATAC Data Analysis Using Omnition PipelineDid You Know that the QX ONE™ Droplet Digital™ PCR System is Optimized for Biopharma?2023 Positive Droplet Award Interview with Dr. Deendayal Patel, PhDPI3K-AKT Pathway ExplainedKey Opinion Leader Dr. Ed Schuuring Discusses the Role of ddPCR in Lung Cancer ResearchDid You Know the QX ONE Droplet Digital PCR System is Trusted by Biopharma ExpertsAdvantages of Multiplexing with Bio-Plex AssaysBio-Rads Leadership Development ProgramDid You Know that Droplet Digital™ PCR is an Ideal Tool for Wastewater-Based Epidemiology?
Bio-Rad Laboratories |

Overcome the Challenges of PK Assay Development Using TrailBlazer Antibodies

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER